Maintenance and down-regulation of primed neutrophil chemiluminescence activity in human whole blood

J Leukoc Biol. 1997 Dec;62(6):837-44. doi: 10.1002/jlb.62.6.837.

Abstract

Priming of polymorphonuclear neutrophils (PMN) in whole blood (by tumor necrosis factor alpha and interleukin-8 for enhancement of luminol-dependent chemiluminescence induced by human complement-opsonized zymosan) was stable for 120 min. In contrast, priming of isolated PMN in plasma-free suspension for responses to opsonized zymosan, formyl-methionyl-leucyl-phenylalanine, and phorbol myristate acetate was markedly less stable. Decay of priming was not due to irreversible inactivation of the terminal CL production machinery because PMN could be reprimed by platelet-activating factor or leukotriene B4. The tumor necrosis factor-alpha-primed state of isolated PMN was stabilized by host plasma in a concentration-dependent fashion. We conclude that PMN priming results in a dynamic state that is reversible. Our findings suggest the existence of blood-borne components that may act to stabilize or modify PMN priming.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Down-Regulation
  • Humans
  • Interleukin-8 / pharmacology
  • Luminescent Measurements
  • Neutrophils / drug effects
  • Neutrophils / metabolism*
  • Respiratory Burst*
  • Tumor Necrosis Factor-alpha / pharmacology

Substances

  • Interleukin-8
  • Tumor Necrosis Factor-alpha